Additional research using prospective or large retrospective cohorts is necessary to validate whether the use of local radiation therapy in addition to BRAF plus MEK inhibitors improves outcomes in patients with BRAF mutant melanoma with brain metastases. This evidence concerns the gene BRAF and melanoma.